Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.21.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 2,772 $ 2,321
Restricted cash 600
Accounts receivable, net of allowance for doubtful accounts of $275 and $25, respectively 8,028 10,338
Other current assets 2,722 3,851
Total current assets 14,122 16,510
Property and equipment, net 7,349 6,814
Other intangible assets, net 11,351 15,849
Goodwill 8,433 8,433
Operating lease right of use assets 4,384 3,892
Other long-term assets 42 42
Total assets 45,681 51,540
Current liabilities:    
Accounts payable 4,511 4,709
Accrued salary and bonus 3,161 2,341
Other accrued expenses 9,795 9,476
Current liabilities from discontinued operations 766 766
Total current liabilities 18,233 17,292
Contingent consideration 1,818 2,391
Operating lease liabilities, net of current portion 3,540 2,591
Line of credit 3,000
Other long-term liabilities 4,637 4,573
Total liabilities 28,228 29,847
Commitments and contingencies (Note 12)  
Stockholders' equity:    
Common stock, $.01 par value; 100,000,000 shares authorized; 4,075,257 and 3,932,370 shares issued, respectively; 4,055,593 and 3,920,589 shares outstanding, respectively 402 393
Additional paid-in capital 184,404 182,514
Accumulated deficit (212,116) (185,665)
Treasury stock, at cost (19,664 and 11,781 shares, respectively) (1,773) (1,721)
Total stockholders' equity (29,083) (4,479)
Total liabilities and stockholders' equity (855) 25,368
Total liabilities, preferred stock and stockholders' equity 45,681 51,540
Series A [Member]    
Current liabilities:    
Preferred stock, $.01 par value; 5,000,000 shares authorized, 270 Series A shares issued and outstanding 47,000 Series B issued and outstanding 26,172
Series B [Member]    
Current liabilities:    
Preferred stock, $.01 par value; 5,000,000 shares authorized, 270 Series A shares issued and outstanding 47,000 Series B issued and outstanding $ 46,536